Prosecution Insights
Last updated: November 20, 2026

Rachel T Sippel, USPTO Patent Examiner

Listed by the USPTO as SIPPEL, RACHEL T

Tech Center 3700 • Art Units: 3636 3771 3785

This examiner grants 52% of resolved cases

Analysis

SIPPEL, RACHEL T examines in USPTO tech center 3700 and art unit 3636. Across 813 resolved cases, the allowance rate is 52.5%, and the median time to allowance is 1409 days. The 58.2% interview lift is substantial in this record, indicating that interviews may be an important tool for improving prosecution outcomes.

The leading companies are James L Orrington Ii D D S P C, Mallinckrodt Pharmaceuticals Ireland Limited, and Fisher & Paykel Healthcare Limited. The listed firms are STITES & HARBISON PLLC, Arch & Lake LLP, and Carlson, Caspers, Vandenburgh & Lindquist, P.A. Practitioners should account for the recorded timing while considering interviews as a central response option.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

52.5%
Allow Rate
-17.5% vs TC avg
862
Total Applications
+58.2%
Interview Lift
1409
Avg Prosecution Days
Based on 813 resolved cases, 2023–2026

Rejection Statute Breakdown

4.2%
§101 Eligibility
15.3%
§102 Novelty
48.9%
§103 Obviousness
26.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18296049 REPLACEABLE FILTER SYSTEMS FOR MECHANICAL VENTILATION Non-Final OA Covidien LP
18315102 RESPIRATOR DEVICES AND FOLDING PATTERNS FOR RESPIRATOR FILTERS Non-Final OA Honeywell Safety Products USA, Inc.
18268205 LOAD DISTRIBUTION DEVICE FOR IMPROVING THE MOBILITY OF THE CENTER OF MASS OF A USER DURING COMPLEX MOTIONS Final Rejection Wistron Corporation
18117917 SYSTEMS AND METHOD FOR DELIVERY OF THERAPEUTIC GAS TO PATIENTS, IN NEED THEREOF, RECEIVING BREATHING GAS FROM A VENTILATOR THAT VARIES AT LEAST PRESSURE AND/OR FLOW USING ENHANCED THERAPEUTIC GAS (NO) FLOW MEASUREMENT Final Rejection Mallinckrodt Pharmaceuticals Ireland Limited
18109506 SYSTEMS AND METHODS FOR INTELLIGENT GAS SOURCE MANAGEMENT Non-Final OA Mallinckrodt Pharmaceuticals Ireland Limited
18467576 NASAL CANNULA WITH FLOW RESTRICTOR Final Rejection Fisher & Paykel Healthcare Limited
17442321 MUFFLER Final Rejection Fisher & Paykel Healthcare Limited
18312837 COMPRESSION GARMENT Final Rejection Koya Medical, Inc.
18559089 SYSTEM AND METHOD FOR LIMB COMPRESSION Non-Final OA Roger TSANG
18001288 HIGH QUALITY MASK Final Rejection NANA PRODUCTS LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Rachel T Sippel's allowance rate?

52.5% of resolved applications examined by Rachel T Sippel were allowed (813 resolved cases), compared with 64.5% across Art Unit 3636 over the last five years.

Does an interview help with examiner Rachel T Sippel?

This examiner's interview lift is +58.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Rachel T Sippel take to allow a patent?

Applications allowed by Rachel T Sippel took 1,409 days on average from filing to allowance.

Which art unit does examiner Rachel T Sippel work in?

Rachel T Sippel examines applications in Art Unit 3636 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month